Download PDF
Horm Metab Res 2018; 50(02): 93-105
DOI: 10.1055/s-0043-125148
Review

The Effects of Folate Supplementation on Diabetes Biomarkers Among Patients with Metabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Maryam Akbari
1   Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
,
Reza Tabrizi
1   Health Policy Research Center, Institute of Health, Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran
,
Kamran B. Lankarani
2   Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
,
Seyed Taghi Heydari
2   Health Policy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
,
Maryam Karamali
3   Department of Gynecology and Obstetrics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Fariba Keneshlou
4   Department of Urology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
,
Kayvan Niknam
5   Department of Anesthesiology and Pain Medicine, Rasoul Akram Medical Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
,
Fariba Kolahdooz
6   Indigenous and Global Health Research, Department of Medicine, University of Alberta, Edmonton, Canada
,
Zatollah Asemi
7   Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
› Author Affiliations Funding The current study was founded by a grant from the Vice-chancellor for Research, SUMS, in Iran.
› Further Information
Also available at
    Permissions and Reprints

Corrected by:

Correction: The Effects of Folate Supplementation on Diabetes Biomarkers Among Patients with Metabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsHorm Metab Res 2018; 50(02): e8-e8
DOI: 10.1055/a-1270-8166

Abstract

Although several studies have evaluated the effect of folate supplementation on diabetes biomarkers among patients with metabolic diseases, findings are inconsistent. This review of randomized controlled trials (RCTs) was performed to summarize the evidence on the effects of folate supplementation on diabetes biomarkers among patients with metabolic diseases. Randomized-controlled trials (RCTs) published in PubMed, EMBASE, Web of Science and Cochrane Library databases up to 1 September 2017 were searched. Two review authors independently assessed study eligibility, extracted data, and evaluated risk of bias of included studies. Heterogeneity was measured with a Q-test and with I2 statistics. Data were pooled by using the fix or random-effect model based on the heterogeneity test results and expressed as standardized mean difference (SMD) with 95% confidence interval (CI). A total of sixteen randomized controlled trials involving 763 participants were included in the final analysis. The current meta-analysis showed folate supplementation among patients with metabolic diseases significantly decreased insulin (SMD –1.28; 95% CI, –1.99, –0.56) and homeostasis model assessment of insulin resistance (HOMA-IR) (SMD –1.28; 95% CI, –1.99, –0.56). However, folate supplementation did not affect fasting plasma glucose (FPG) (SMD –0.30; 95% CI, –0.63, 0.02) and hemoglobin A1C (HbA1c) (SMD –0.29; 95% CI, –0.61, 0.03). The results of this meta-analysis study demonstrated that folate supplementation may result in significant decreases in insulin levels and HOMA-IR score, but does not affect FPG and HbA1c levels among patients with metabolic diseases.

Key words

folate supplementation - diabetes biomarkers - metabolic diseases - meta-analysis


Publication History

Received: 14 September 2017

Accepted: 11 December 2017

Article published online:
17 January 2018

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Li Y, Yang G, Qiang J, Cai S, Zhou H. Incidence of insulin resistance and diabetes in patients with portosystemic shunts without liver dysfunction. J Int Med Res 2016; 44: 1040-1048
    CrossrefPubMedGoogle Scholar
  • 2 Ricci G, Pirillo I, Tomassoni D, Sirignano A, Grappasonni I. Metabolic syndrome, hypertension, and nervous system injury: Epidemiological correlates. Clin Exp Hypertens 2017; 39: 8-16
    CrossrefPubMedGoogle Scholar
  • 3 Chiu WL, Boyle J, Vincent A, Teede H, Moran LJ. Cardiometabolic risks in polycystic ovary syndrome: Non-traditional risk factors and the impact of obesity. Neuroendocrinology 2017; 104: 412-424
    CrossrefPubMedGoogle Scholar
  • 4 Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, Colarieti G, La Sala G, Colao A, Yildiz BO. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: An uptodate in the management of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2016; 207: 214-219
    CrossrefPubMedGoogle Scholar
  • 5 Arredondo A. Diabetes: A global challenge with high economic burden for public health systems and society. Am J Public Health 2013; 103: e1-e2
    CrossrefPubMedGoogle Scholar
  • 6 Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt Jr PI. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J 2016; 473: 4527-4550
    CrossrefPubMedGoogle Scholar
  • 7 Satapati S, Kucejova B, Duarte JA, Fletcher JA, Reynolds L, Sunny NE, He T, Nair LA, Livingston KA, Fu X, Merritt ME, Sherry AD, Malloy CR, Shelton JM, Lambert J, Parks EJ, Corbin I, Magnuson MA, Browning JD, Burgess SC. Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. J Clin Invest 2015; 125: 4447-4462
    CrossrefPubMedGoogle Scholar
  • 8 Ruhe RC, McDonald RB. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr 2001; 20: 363S-369S discussion 81S–83S
    CrossrefPubMedGoogle Scholar
  • 9 Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: A double blind trial. Eur Rev Med Pharmacol Sci 2011; 15: 509-514
    PubMedGoogle Scholar
  • 10 Kazerooni T, Asadi N, Dehbashi S, Zolghadri J. Effect of folic acid in women with and without insulin resistance who have hyperhomocysteinemic polycystic ovary syndrome. Int J Gynaecol Obstet 2008; 101: 156-160
    CrossrefPubMedGoogle Scholar
  • 11 Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome. Gynecol Endocrinol 2007; 23: 505-510
    CrossrefPubMedGoogle Scholar
  • 12 Bherwani S, Saumya AS, Ahirwar AK, Sandhya AS, Prajapat B, Patel S, Singh R, Ghotekar LH. The association of folic acid deficiency and diabetic nephropathy in patients with type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets 2016 [Epub ahead of print]
    PubMed
  • 13 Peng Y, Dong B, Wang Z. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: A cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES). Int J Cardiol 2016; 219: 136-142
    CrossrefPubMedGoogle Scholar
  • 14 Talari HR, Rafiee M, Farrokhian A, Raygan F, Bahmani F, Darooghegi Mofrad M, Hamidian Y, Tamtaji OR, Karamali F, Asemi Z. The Effects of Folate supplementation on carotid intima-media thickness and metabolic status in patients with metabolic syndrome. Ann Nutr Metab 2016; 69: 41-50
    CrossrefPubMedGoogle Scholar
  • 15 Asemi Z, Karamali M, Esmaillzadeh A. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res 2014; 58: 1465-1473
    PubMedGoogle Scholar
  • 16 Vijayakumar A, Kim EK, Kim H, Choi YJ, Huh KB, Chang N. Effects of folic acid supplementation on serum homocysteine levels, lipid profiles, and vascular parameters in post-menopausal Korean women with type 2 diabetes mellitus. Nutr Res Pract 2017; 11: 327-333
    CrossrefPubMedGoogle Scholar
  • 17 Sudchada P, Saokaew S, Sridetch S, Incampa S, Jaiyen S, Khaithong W. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2012; 98: 151-158
    CrossrefPubMedGoogle Scholar
  • 18 Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: A meta-analysis of randomized controlled trials. JAMA 2006; 296: 2720-2726
    CrossrefPubMedGoogle Scholar
  • 19 Asemi Z, Karamali M, Esmaillzadeh A. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial. Mol Nutr Food Res 2014; 58: 1465-1473
    CrossrefPubMedGoogle Scholar
  • 20 Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, Magni F, Sandoli EP, Lucotti P, Costa S. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: Relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004; 151: 483-489
    PubMedGoogle Scholar
  • 21 Moosavi Z, Khorasani JM, Shakeri MT, Mazloum KZ. The role of folate and vitamin B12 serum levels of homocysteine in diabetic patients treated with metformin. Med J Mashhad 58: 237-242
    PubMedGoogle Scholar
  • 22 Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pract 2011; 94: 33-38
    CrossrefPubMedGoogle Scholar
  • 23 Kilicdag EB, Bagis T, Tarim E, Aslan E, Erkanli S, Simsek E, Haydardedeoglu B, Kuscu E. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: A randomized trial. Hum Reproduct 2005; 20: 1521-1528
    CrossrefPubMedGoogle Scholar
  • 24 Solini A, Santini E, Ferrannini E. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects. Int J Obesity 2006; 30: 1197
    CrossrefPubMedGoogle Scholar
  • 25 Chen G, Shi L, Cai L, Lin W, Huang H, Liang J, Li L, Lin L, Tang K, Chen L, Lu J, Bi Y, Wang W, Ning G, Wen J. Comparison of insulin resistance and beta-cell dysfunction between the young and the elderly in normal glucose tolerance and prediabetes population: A prospective study. Horm Metab Res 2017; 49: 135-141
    PubMedGoogle Scholar
  • 26 Belviranli M, Okudan N, Celik F. Association of circulating irisin with insulin resistance and oxidative stress in obese women. Horm Metab Res 2016; 48: 653-657
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Abruzzese GA, Cerrrone GE, Gamez JM, Graffigna MN, Belli S, Lioy G, Mormandi E, Otero P, Levalle OA, Motta AB. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as markers of insulin resistance and metabolic associated disturbances in young argentine women with polycystic ovary syndrome. Horm Metab Res 2017; 49: 23-29
    PubMedGoogle Scholar
  • 28 Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: A randomized controlled clinical trial. Horm Metab Res 2015; 47: 232-238
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr 2015; 34: 586-592
    CrossrefPubMedGoogle Scholar
  • 30 Chapman K. Can people make healthy changes to their diet and maintain them in the long term? A review of the evidence. Appetite 2010; 54: 433-441
    CrossrefPubMedGoogle Scholar
  • 31 Roumen C, Blaak EE, Corpeleijn E. Lifestyle intervention for prevention of diabetes: Determinants of success for future implementation. Nutr Rev 2009; 67: 132-146
    CrossrefPubMedGoogle Scholar
  • 32 Turner T, Stein EA. Non-statin treatments for managing LDL cholesterol and their outcomes. Clin Ther 2015; 37: 2751-2769
    CrossrefPubMedGoogle Scholar
  • 33 Brown MT, Bussell JK. Medication adherence: WHO cares?. Mayo Clin Proc 2011; 86: 304-314
    CrossrefPubMedGoogle Scholar
  • 34 Pirro M, Mannarino MR, Bianconi V, Simental-Mendia LE, Bagaglia F, Mannarino E, Sahebkar A. The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 2016; 110: 76-88
    CrossrefPubMedGoogle Scholar
  • 35 Spoelstra-de MA, Brouwer CB, Terheggen F, Bollen JM, Stehouwer CD, Smulders YM. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia. Neth J Med 2004; 62: 246-253
    PubMedGoogle Scholar
  • 36 McNulty H, Pentieva K, Hoey L, Ward M. Homocysteine, B-vitamins and CVD. Proc Nutr Soc 2008; 67: 232-237
    CrossrefPubMedGoogle Scholar
  • 37 Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pedersen EK, Nygard O. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 2008; 300: 795-804
    CrossrefPubMedGoogle Scholar
  • 38 Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest Jr J. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 2006; 354: 1567-1577
    CrossrefPubMedGoogle Scholar
  • 39 Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: A randomised placebo controlled trial. BMJ 2010; 341: c6273
    CrossrefPubMedGoogle Scholar
  • 40 Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565-575
    CrossrefPubMedGoogle Scholar
  • 41 Spence JD. Homocysteine-lowering therapy: A role in stroke prevention?. Lancet Neurol 2007; 6: 830-838
    CrossrefPubMedGoogle Scholar
  • 42 Refsum H, Smith AD. Homocysteine, B vitamins, and cardiovascular disease. N Engl J Med 2006; 355: 207 authors’ reply 9–11
    PubMedGoogle Scholar
  • 43 Buettner R, Bettermann I, Hechtl C, Gabele E, Hellerbrand C, Scholmerich J, Bollheimer LC. Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome. Horm Metab Res 2010; 42: 769-774
    Article in Thieme ConnectPubMedGoogle Scholar
  • 44 Najib S, Sanchez-Margalet V. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect. J Mol Endocrinol 2001; 27: 85-91
    CrossrefPubMedGoogle Scholar
  • 45 Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino Sr. RB, Wilson PW. Fasting plasma homocysteine levels in the insulin resistance syndrome: The Framingham offspring study. Diabetes Care 2001; 24: 1403-1410
    CrossrefPubMedGoogle Scholar
  • 46 Sanchez-Margalet V, Valle M, Ruz FJ, Gascon F, Mateo J, Goberna R. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects. J Nutr Biochem. 2002; 13: 75-79
    CrossrefPubMedGoogle Scholar
  • 47 Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H, Stehouwer CD. Insulin resistance is associated with elevated plasma total homocysteine levels in healthy, non-obese subjects. Atherosclerosis 1998; 139: 197-198
    PubMedGoogle Scholar
  • 48 Wittmann I, Nagy J. Are insulin resistance and atherosclerosis the consequences of oxidative stress?. Diabetologia 1996; 39: 1002-1003
    CrossrefPubMedGoogle Scholar
  • 49 Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-318
    CrossrefPubMedGoogle Scholar
  • 50 Setola E, Monti LD, Galluccio E, Palloshi A, Fragasso G, Paroni R, Magni F, Sandoli EP, Lucotti P, Costa S, Fermo I, Galli-Kienle M, Origgi A, Margonato A, Piatti P. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: Relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 2004; 151: 483-489
    CrossrefPubMedGoogle Scholar
  • 51 Mangoni AA, Sherwood RA, Asonganyi B, Swift CG, Thomas S, Jackson SH. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens 2005; 18: 220-226
    CrossrefPubMedGoogle Scholar
  • 52 Alian Z, Hashemipour M, Dehkordi EH, Hovsepian S, Amini M, Moadab MH, Javanmard SH. The effects of folic acid on markers of endothelial function in patients with type 1 diabetes mellitus. Med Archiv 2012; 66: 12
    CrossrefPubMedGoogle Scholar
  • 53 Bahmani F, Karamali M, Shakeri H, Asemi Z. The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial. Clin Endocrinol 2014; 81: 582-587
    CrossrefPubMedGoogle Scholar
  • 54 Dehkordi EH, Sedehi M, Shahraki ZG, Najafi R. Effect of folic acid on homocysteine and insulin resistance of overweight and obese children and adolescents. Adv Biomed Res 2016; 5: 88
    CrossrefPubMedGoogle Scholar
  • 55 Khiavi A, Gargari P, Asgharzadeh A. Effect of folic acid supplementation on indices of glycemic control, insulin resistance and lipid profile in patients with type 2 diabetes mellitus. Iran J Endocrinol Metab 2011; 13: 354-360
    PubMedGoogle Scholar
  • 56 Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA. Folic acid improves endothelial dysfunction in type 2 diabetes-an effect independent of homocysteine-lowering. Vascul Med 2006; 11: 101-109
    CrossrefPubMedGoogle Scholar
  • 57 Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002; 105: 22-26
    CrossrefPubMedGoogle Scholar
  • 58 Sheu WH-H, Chin H-ML, Lee W-J, Wan C-J, Su H-Y, Lang H-F. Prospective evaluation of folic acid supplementation on plasma homocysteine concentrations during weight reduction: A randomized, double-blinded, placebo-controlled study in obese women. Life Sci 2005; 76: 2137-2145
    CrossrefPubMedGoogle Scholar
  • 59 Peña AS, Wiltshire E, Gent R, Hirte C, Couper J. Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J Pediatr 2004; 144: 500-504
    CrossrefPubMedGoogle Scholar